IL13RA2 and glioblastoma: Pandya H et al. (2012) elucidated the selective binding affinity of the peptide “Pep-1L” for IL-13Rα2, identifying a non-competitive binding domain distinct from the IL-13 interaction site within a GBM xenograft model.